Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Argus Biomedical
New artificial cornea offers promise for patients who reject human tissue
September 10th, 2003
Corneal transplantation, second only to blood transfusions as the oldest and most successful human transplant procedure, enters a new era today with the introduction of the AlphaCor artificial cornea. AlphaCor, a one-piece, soft, flexible hydrogel polymer substance, evolved from extensive laboratory and clinical research internationally and represents a revolutionary keratoprosthess - a true artificial cornea. David R. Hardten, founding partner and director of research at Minnesota Eye Consultants, performed a 3-hour stage I surgery recently to surgically implant the AlphaCor in a patient who had previously rejected conventional donor grafts. The...
Source: Biotech Week (2003-09-10)
|
